Novavax (Maryland) Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 21

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 5

  • Investments
  • 1

Novavax (Maryland) General Information

Description

Operator of a vaccine adjuvant company based in Uppsala. Sweden. The company develops vaccines for veterinary and human. It offers human influenza vaccine Matrix-M and other vaccination products for dogs, cats, fishes and all other animals.

Contact Information

Website
isconova.com
Formerly Known As
Isconova
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Kungsgatan, 109
  • 753 18 Uppsala
  • Sweden
+46 018-16
Primary Industry
Other Commercial Products
Other Industries
Other Pharmaceuticals and Biotechnology
Acquirer
Corporate Office
  • Kungsgatan, 109
  • 753 18 Uppsala
  • Sweden
+46 018-16

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Novavax (Maryland) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Novavax (Maryland)‘s full profile, request access.

Request a free trial

Novavax (Maryland) Patents

Novavax (Maryland) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-2805741-A1 Composition including an iscom matrix and ectodomains Active 23-Jul-2010
CA-2805741-C Composition including an iscom matrix and ectodomains Active 23-Jul-2010
AU-2011280259-A1 Influenza vaccine Active 23-Jul-2010
AU-2011280259-A8 Influenza vaccine Active 23-Jul-2010
AU-2011280259-B2 Influenza vaccine Active 23-Jul-2010 A61K39/145
To view Novavax (Maryland)’s complete patent history, request access »

Novavax (Maryland) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Novavax (Maryland) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Novavax (Maryland)‘s full profile, request access.

Request a free trial

Novavax (Maryland) Acquisitions (1)

Novavax (Maryland)’s most recent deal was a Merger/Acquisition with Nordic Vaccine for . The deal was made on 02-May-2011.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Nordic Vaccine 02-May-2011 Merger/Acquisition Biotechnology
To view Novavax (Maryland)’s complete acquisitions history, request access »

Novavax (Maryland) FAQs

  • When was Novavax (Maryland) founded?

    Novavax (Maryland) was founded in 2000.

  • Where is Novavax (Maryland) headquartered?

    Novavax (Maryland) is headquartered in Uppsala, Sweden.

  • What is the size of Novavax (Maryland)?

    Novavax (Maryland) has 21 total employees.

  • What industry is Novavax (Maryland) in?

    Novavax (Maryland)’s primary industry is Other Commercial Products.

  • Is Novavax (Maryland) a private or public company?

    Novavax (Maryland) is a Private company.

  • What is the current valuation of Novavax (Maryland)?

    The current valuation of Novavax (Maryland) is .

  • What is Novavax (Maryland)’s current revenue?

    The current revenue for Novavax (Maryland) is .

  • How much funding has Novavax (Maryland) raised over time?

    Novavax (Maryland) has raised $16.8M.

  • Who are Novavax (Maryland)’s investors?

    Farstorp Invest, InnovationsKapital, LMK Venture, Sunstone Life Science Ventures, and Uppsala Innovation Centre have invested in Novavax (Maryland).

  • When was Novavax (Maryland) acquired?

    Novavax (Maryland) was acquired on 22-Aug-2013.

  • Who acquired Novavax (Maryland)?

    Novavax (Maryland) was acquired by Novavax.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process